The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target.
about
Wnt5a Deficiency Leads to Anomalies in Ureteric Tree Development, Tubular Epithelial Cell Organization and Basement Membrane Integrity Pointing to a Role in Kidney Collecting Duct PatterningApplication of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: In Vitro and in Vivo Study.The Wnt/β-catenin signaling pathway regulates the development of airway remodeling in patients with asthma.Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased β-catenin inhibition and increased Wnt5a/b interaction.Identification of Differentially Expressed Genes in Pelvic Organ Prolapse by RNA-Seq.Desmoid Fibromatosis of the Abdominal Wall: Surgical Resection and Reconstruction with Biological Matrix Egis®Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Gliosarcomas lack BRAFV600E mutation, but a subset exhibit β-catenin nuclear localization.Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis.Wnt/β-catenin Signaling Pathway Regulates Specific lncRNAs That Impact Dermal Fibroblasts and Skin Fibrosis.Exon 3 mutations of CTNNB1 drive tumorigenesis: a review.A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates.CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled To Cullin-RING Ubiquitin Ligase Activation.
P2860
Q27329684-55EF2822-5652-4B82-AE29-C61D7EB59972Q36324771-1B5890E1-D414-4B90-B3E7-B959434CC0E3Q36392172-74CCB087-51CE-48E8-8920-AF39081D33E9Q36773752-5B272D5F-A20D-4B3D-B6D7-0098E317B13FQ37415546-07EA9CCA-6D81-43BD-A6C1-659AF4BDBFD1Q37695123-08A32FD3-D809-458B-B0BC-8BF40005A7FAQ38649653-4E147F8D-632E-4BC8-B038-137B11C6E8E1Q43410036-FB568A92-7BD2-45DB-A37C-D835DBF8385EQ45073622-13ED6D9D-2564-4E67-9492-F370DE34F818Q47100891-F74B2037-31B8-4053-A05B-DCCF66434F25Q49427525-1BDA7135-FFC8-4B92-9D11-A7BDFE75D8DAQ50058176-F91BF2F2-EA90-4EE7-8E08-9CDD2FDCA5B7Q50309115-03414A9C-892E-40C9-9EA4-DF1E0595B1A9
P2860
The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@ast
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@en
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@nl
type
label
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@ast
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@en
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@nl
prefLabel
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@ast
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@en
The Wnt/β-catenin pathway in h ...... ility as a therapeutic target.
@nl
P2093
P2860
P1476
The Wnt/β-catenin pathway in h ...... bility as a therapeutic target
@en
P2093
Daniela Segat
Marco Rastrelli
Maria Vittoria Enzo
P2860
P2888
P356
10.1186/S40591-015-0038-2
P577
2015-01-30T00:00:00Z
P5875
P6179
1047817149